PharmacokineticsAbsorption:Thehalf-lifeofFRAGMINhasbeenshowntobe2hoursafterintravenousinjectionand3-4hoursaftersubcutaneousinjection.Thebioavailabilityaftersubcutaneousinjectionisapproximately90％andth
ACTIONANDCLINICALPHARMACOLOGYMechanismofActionFRAGMINisalowmolecularweightheparinwithantithromboticproperties.Dalteparinsodiumisproducedthroughcontrollednitrousaciddepolymerizationofsodiumheparinfromp
Enoxaparinisusedtopreventandtreatharmfulbloodclots.Thishelpstoreducetheriskofastrokeorheartattack.Thismedicationhelpskeepyourbloodflowingsmoothlybyloweringtheactivityofclottingproteinsintheblood.Enoxa
Dalteparinisananticoagulantthathelpspreventtheformationofbloodclots.Dalteparinisusedtogetherwithaspirintopreventbloodvesselcomplicationsinpeoplewithcertaintypesofangina(chestpain)orheartattack.Daltepa
Dalteparincomesasasasolution(liquid)invialsandprefilledsyringestoinjectsubcutaneously(undertheskin).Itisusuallygivenonceaday,butmaybegiventwiceadayforcertainconditions.Thelengthofyourtreatmentdependso